Venthera, Inc., a BridgeBio company
1 clinical trials · Sponsor
◉ Watch Venthera, Inc., a BridgeBio company
| Record | Firm | Date |
|---|---|---|
| First in Human Trial of Topical VT30 in Pts With Venous/Lymphatic Malformations Assoc With PIK3CA or TEK Gene Mutations (NCT04409145) | Venthera, Inc., a BridgeBio company | 2020-10-01 |
Track Venthera, Inc., a BridgeBio company automatically
Every clearance here is in the API, with alerts when new ones post.